162 related articles for article (PubMed ID: 8222103)
21. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.
Grines CL; Browne KF; Marco J; Rothbaum D; Stone GW; O'Keefe J; Overlie P; Donohue B; Chelliah N; Timmis GC
N Engl J Med; 1993 Mar; 328(10):673-9. PubMed ID: 8433725
[TBL] [Abstract][Full Text] [Related]
22. Stroke complicating acute myocardial infarction. A meta-analysis of risk modification by anticoagulation and thrombolytic therapy.
Vaitkus PT; Berlin JA; Schwartz JS; Barnathan ES
Arch Intern Med; 1992 Oct; 152(10):2020-4. PubMed ID: 1417374
[TBL] [Abstract][Full Text] [Related]
23. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Analyses of patient subgroups in the Thrombolysis in Myocardial Infarction (TIMI) trial, phase II.
Mueller HS; Cohen LS; Braunwald E; Forman S; Feit F; Ross A; Schweiger M; Cabin H; Davison R; Miller D
Circulation; 1992 Apr; 85(4):1254-64. PubMed ID: 1555269
[TBL] [Abstract][Full Text] [Related]
24. Clinical characteristics and mid-term outcomes of acute myocardial infarction patients with prior cerebrovascular disease in an Asian population: Lessons from the Korea Acute Myocardial Infarction Registry.
Li YJ; Rha SW; Chen KY; Jin Z; Minami Y; Wang L; Dang Q; Poddar KL; Ramasamy S; Park JY; Oh DJ; Jeong MH;
Clin Exp Pharmacol Physiol; 2010 May; 37(5-6):581-6. PubMed ID: 20105192
[TBL] [Abstract][Full Text] [Related]
25. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study.
Tung CY; Granger CB; Sloan MA; Topol EJ; Knight JD; Weaver WD; Mahaffey KW; White H; Clapp-Channing N; Simoons ML; Gore JM; Califf RM; Mark DB
Circulation; 1999 Jan; 99(3):370-6. PubMed ID: 9918523
[TBL] [Abstract][Full Text] [Related]
26. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ
Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656
[TBL] [Abstract][Full Text] [Related]
27. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
Mahaffey KW; Granger CB; Sloan MA; Green CL; Gore JM; Weaver WD; White HD; Simoons ML; Barbash GI; Topol EJ; Califf RM
Am Heart J; 1999 Sep; 138(3 Pt 1):493-9. PubMed ID: 10467200
[TBL] [Abstract][Full Text] [Related]
28. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators.
Becker RC; Terrin M; Ross R; Knatterud GL; Desvigne-Nickens P; Gore JM; Braunwald E
Ann Intern Med; 1994 Apr; 120(8):638-45. PubMed ID: 8135447
[TBL] [Abstract][Full Text] [Related]
29. Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli Thrombolytic National Survey).
Gottlieb S; Boyko V; Zahger D; Balkin J; Hod H; Pelled B; Stern S; Behar S
J Am Coll Cardiol; 1996 Nov; 28(6):1506-13. PubMed ID: 8917265
[TBL] [Abstract][Full Text] [Related]
30. Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators.
Lee KL; Woodlief LH; Topol EJ; Weaver WD; Betriu A; Col J; Simoons M; Aylward P; Van de Werf F; Califf RM
Circulation; 1995 Mar; 91(6):1659-68. PubMed ID: 7882472
[TBL] [Abstract][Full Text] [Related]
31. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.
Gurwitz JH; Gore JM; Goldberg RJ; Barron HV; Breen T; Rundle AC; Sloan MA; French W; Rogers WJ
Ann Intern Med; 1998 Oct; 129(8):597-604. PubMed ID: 9786806
[TBL] [Abstract][Full Text] [Related]
32. [Sex differences in incidence of mortality after acute myocardial infarction].
Trappolini M; Chillotti FM; Rinaldi R; Trappolini F; Coclite D; Napoletano AM; Matteoli S
Ital Heart J Suppl; 2002 Jul; 3(7):759-66. PubMed ID: 12187637
[TBL] [Abstract][Full Text] [Related]
33. Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators.
Stone GW; Grines CL; Browne KF; Marco J; Rothbaum D; O'Keefe JH; Hartzler GO; Overlie P; Donohue B; Chelliah N; Vlietstra R; Puchrowicz-Ochocki S; O'Neill WW
Cathet Cardiovasc Diagn; 1996 Dec; 39(4):333-9. PubMed ID: 8958418
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Mahaffey KW; Granger CB; Sloan MA; Thompson TD; Gore JM; Weaver WD; White HD; Simoons ML; Barbash GI; Topol EJ; Califf RM
Circulation; 1998 Mar; 97(8):757-64. PubMed ID: 9498539
[TBL] [Abstract][Full Text] [Related]
35. Incidence, clinical characteristics, and prognostic significance of right bundle-branch block in acute myocardial infarction: a study in the thrombolytic era.
Melgarejo-Moreno A; Galcerá-Tomás J; Garciá-Alberola A; Valdés-Chavarri M; Castillo-Soria FJ; Mira-Sánchez E; Gil-Sánchez J; Allegue-Gallego J
Circulation; 1997 Aug; 96(4):1139-44. PubMed ID: 9286941
[TBL] [Abstract][Full Text] [Related]
36. Comparison of primary angioplasty versus thrombolytic therapy for acute myocardial infarction. Alabama Registry of Myocardial Ischemia Investigators.
Rogers WJ; Dean LS; Moore PB; Wool KJ; Burgard SL; Bradley EL
Am J Cardiol; 1994 Jul; 74(2):111-8. PubMed ID: 8023773
[TBL] [Abstract][Full Text] [Related]
37. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.
Granger CB; Hirsch J; Califf RM; Col J; White HD; Betriu A; Woodlief LH; Lee KL; Bovill EG; Simes RJ; Topol EJ
Circulation; 1996 Mar; 93(5):870-8. PubMed ID: 8598077
[TBL] [Abstract][Full Text] [Related]
38. Impact of gender on treatment and clinical outcomes in acute ST elevation myocardial infarction patients in Thailand.
Srichaiveth B; Ruengsakulrach P; Visudharom K; Sanguanwong S; Tangsubutr W; Insamian P
J Med Assoc Thai; 2007 Oct; 90 Suppl 1():65-73. PubMed ID: 18431888
[TBL] [Abstract][Full Text] [Related]
39. Mortality differences between men and women following first myocardial infarction. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempo de Espera.
Marrugat J; Sala J; Masiá R; Pavesi M; Sanz G; Valle V; Molina L; Serés L; Elosua R
JAMA; 1998 Oct; 280(16):1405-9. PubMed ID: 9800999
[TBL] [Abstract][Full Text] [Related]
40. Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study.
Zuanetti G; Latini R; Maggioni AP; Santoro L; Franzosi MG
J Am Coll Cardiol; 1993 Dec; 22(7):1788-94. PubMed ID: 8245329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
